Animals balance nutritional state and energy expenditure in order to achieve metabolic homeostasis ([@bib58]; [@bib65]). In the fruit fly, *Drosophila melanogaster*, feeding behavior and metabolism are regulated by non-neuronal tissues including the muscle, the adipose-like organ called the fat body, and the gastrointestinal tract ([@bib17]; [@bib28]). Similarly, in mammals, endocrine hormones such as ghrelin, leptin, insulin, and glucagon are secreted from the stomach, adipose tissue, and pancreas, to convey nutritional status to the brain regions that regulate sleep and metabolism ([@bib42]; [@bib9]; [@bib30]). Dysregulation of non-neuronal hormonal signals leads to a number of metabolic diseases including obesity, diabetes, and insomnia ([@bib4]). Therefore, mechanistic investigation of factors regulating brain-periphery communication is critical to understanding disorders associated with sleep and metabolism.

Adipose tissue senses overall nutrient levels in the animal and modulates hunger-induced behaviors through controlling energy storage and secreting factors that act on the nervous system to affect behavior ([@bib63]; [@bib53]; [@bib46]). The insect fat body is central to the control of energy homeostasis. It is the primary site of glycogen and triglyceride storage, and the main detoxification organ in the fly, thereby exhibiting functions analogous to the mammalian liver and adipose tissue ([@bib5]). Genome-wide transcriptome analysis has identified many genes that are upregulated during starvation, including metabolic enzymes, cytochromes, metabolite transporters, kinases, and proteins involved in lipid metabolism ([@bib22]). Even though the primary function of many of these genes in the regulation of energy storage has been studied in detail, little is known about how they may impact sleep and other behaviors.

Many of the genes and transmitters required for metabolic regulation of sleep and feeding in mammals are conserved in *Drosophila* ([@bib2]; [@bib49]), and numerous conserved factors have been identified that regulate sleep and metabolic function ([@bib4]; [@bib65]). The *GAL4*/*UAS* system, in combination with genome-wide RNAi libraries, allow for selectively decreasing gene expression in the fly fat body and then measuring the effects on sleep ([@bib7]; [@bib14]). Growing evidence suggests that the fat body regulates complex behaviors including sleep ([@bib34]; [@bib32]; [@bib61]), yet the molecular basis through which the fat body regulates sleep remains poorly understood.

Here, we sought to identify sleep regulators in the fat body by selectively decreasing the expression of genes that have been previously identified to be upregulated in starved flies and then measuring their effects on sleep ([@bib22]). We identified that *Phosphoribosylformylglycinamidine synthase (Ade2*), a highly conserved gene involved in the biosynthesis of purines, is required for normal sleep in flies. Flies deficient for *Ade2* are short-sleepers and have reduced triglyceride stores, suggesting that loss of *Ade2* impairs energy storage and inhibits sleep. Disruption of *Ade2* in the fat body does not disrupt arousal threshold and homeostatic response to sleep deprivation, suggesting a specific role in modulating baseline sleep duration. These findings provide a novel factor that functions in the fat body to regulate sleep, and support growing evidence that a non-neuronal metabolic tissue is critical for the proper regulation of sleep.

Methods {#s1}
=======

Fly Stocks {#s2}
----------

Flies were grown and maintained on standard food (Bloomington Recipe, Genesee Scientific). Flies were kept in incubators (Powers Scientific; Dros52) at 25° on a 12:12 LD cycle with humidity set to 55--65%. The background control line used in this study is *w^1118^* fly strain, and all experimental flies were outcrossed 6-8 generations into this background, unless already in this background. The following fly strains were ordered from Bloomington Stock Center, *w^1118^*(5905; [@bib36]),*CG-GAL4* (7011; [@bib6]), *r^4^-GAL4*(33832; [@bib35]), and *hmlΔ3-GAL4* (30141; [@bib21]). *Ade2^3-20^*, *Ade2^1-6^*, and *UAS-Ade2* were obtained from D. Clark and have been previously characterized ([@bib26]). *Drosophila* lines used in the RNAi screen originate from the TRiP collection ([@bib7]; [@bib48]) and are described in ([Table 1](#t1){ref-type="table"}).

###### RNAi lines used for fat body screen

                BL Stock \#                Total Sleep   Day Sleep   Night sleep   Waking activity   Total bout   ABL
  ------------- ------------- ------------ ------------- ----------- ------------- ----------------- ------------ -------
  FBgn0012034   41917         AcCOAs       1030.63       339.06      691.56        1.05              27.50        39.46
  FBgn0000052   36686         ade2         722.50        67.50       655.00        0.88              17.67        42.63
  FBgn0000078   57561         Amy-D        1025.42       351.67      673.75        0.92              29.83        36.56
  FBgn0036449   25926         bmm          1057.33       392.00      665.33        1.16              30.82        36.44
  FBgn0039241   53332         CG11098      979.06        284.06      695.00        0.66              22.88        46.56
  FBgn0039649   34885         CG11198      1136.25       460.31      675.94        1.06              24.25        55.81
  FBgn0034721   38214         CG11298      1212.50       503.75      708.75        1.07              23.50        52.07
  FBgn0039299   57194         CG11854      1085.00       402.92      682.08        1.20              32.67        35.62
  FBgn0039649   51476         CG11899      899.06        245.00      654.06        0.75              33.38        28.42
  FBgn0039330   53379         CG11909      1085.63       419.38      666.25        0.78              29.19        41.18
  FBgn0035228   40936         CG12091      1040.31       345.63      694.69        0.86              27.75        38.68
  FBgn0027842   33635         CG12891      1060.00       397.50      662.50        0.97              30.20        41.02
  FBgn0036419   58240         CG13482      1051.88       355.31      696.56        0.93              19.88        54.49
  FBgn0034404   50676         CG15101      879.00        204.50      674.50        0.71              27.20        33.02
  FBgn0025803   35341         CG17299      936.25        262.19      674.06        0.80              26.88        37.55
  FBgn0035108   35188         CG18374      979.09        299.55      679.55        0.98              30.64        34.73
  FBgn0034382   44510         CG18609      967.19        267.67      696.33        1.07              24.40        42.31
  FBgn0029823   57739         CG3011       1095.00       415.00      680.00        0.76              28.78        41.68
  FBgn0031645   43179         CG3036       830.00        168.75      661.25        0.86              23.25        37.89
  FBgn0039361   31150         CG31092      991.25        325.31      665.94        1.51              32.81        37.64
  FBgn0038463   35245         CG3534       866.25        233.13      633.13        0.93              33.43        28.72
  FBgn0023507   53355         CG3835       1031.50       351.50      680.00        0.89              31.20        34.95
  FBgn0034664   61330         CG4377       907.22        223.89      683.33        0.67              27.56        35.32
  FBgn0032349   55629         CG4779       1084.06       385.94      698.13        1.23              22.88        50.50
  FBgn0035950   60091         CG5288       1025.94       329.38      696.56        0.72              27.31        39.24
  FBgn0039493   35486         CG5889       963.13        276.33      692.33        1.30              25.73        39.07
  FBgn0029831   33932         CG5966       828.93        179.29      649.64        0.85              29.36        29.72
  FBgn0034247   60372         CG6484       1200.00       477.00      707.00        1.09              17.40        75.96
  FBgn0036030   60086         CG6767       1177.00       484.00      693.00        0.83              24.40        52.88
  FBgn0033385   38305         CG8055       1043.24       367.65      675.59        0.85              27.41        39.16
  FBgn0034003   57404         CG8094       963.13        300.94      662.19        0.75              32.25        30.98
  FBgn0022073   36667         CG8846       1013.13       311.88      701.25        0.72              23.50        44.63
  FBgn0031689   53892         Cyp28d1      1056.56       368.44      688.13        0.80              26.75        42.65
  FBgn0015714   33887         Cyp6a17      975.50        311.00      664.50        1.10              32.80        32.07
  FBgn0000473   64008         Cyp6a2       1011.79       335.71      676.07        0.96              25.07        43.28
  FBgn0037249   27565         EIF-S10      869.69        180.31      689.38        0.68              23.30        37.87
  FBgn0033465   56864         Etf-QO       887.14        281.43      605.71        0.90              32.71        30.25
  FBgn0263773   63980         FOK          1040.45       353.64      686.82        0.73              28.91        39.11
  FBgn0030013   31118         GIIIspla2    985.00        318.75      666.25        1.02              32.56        32.29
  FBgn0030484   36717         GstT4        858.00        165.00      693.00        0.71              23.30        38.88
  FBgn0001565   28991         hlc          925.83        238.08      673.33        0.90              21.92        44.75
  FBgn0001208   29540         Hn           812.81        187.19      625.63        1.49              25.69        35.12
  FBgn0264785   34717         hph          885.00        195.94      689.06        1.27              24.13        39.14
  FBgn0034329   42599         IM1          1041.00       360.00      681.00        0.86              22.90        47.18
  FBgn0025583   28788         IM2          875.31        237.50      637.81        1.63              25.06        36.49
  FBgn0038465   57814         IRC          938.13        306.47      628.24        1.08              37.94        28.36
  FBgn0001301   31251         Kelch 1      1042.50       347.50      695.00        0.73              26.29        42.49
  FBgn0001301   55612         Kelch 2      1025.31       334.38      690.94        0.95              29.00        37.14
  FBgn0034140   60400         Limostatin   1077.81       401.25      676.56        0.95              25.00        45.52
  FBgn0017581   28357         LK6 1        1044.17       380.83      663.33        0.88              32.92        33.61
  FBgn0017581   35352         LK6 2        905.94        196.25      709.69        0.65              22.56        42.63
  FBgn0030608   32846         lsd2         1088.62       397.76      690.86        1.46              26.86        53.74
  FBst0056039   56039         lsp1         996.00        311.50      684.50        0.82              27.20        38.87
  FBst0031603   31603         luc          975.32        292.62      682.70        1.18              27.20        38.49
  FBgn0033296   62252         MALA7        1039.06       396.56      642.50        1.03              31.25        38.96
  FBgn0033297   55193         MALA8        1061.25       383.33      677.92        0.91              25.83        43.76
  FBgn0032381   55346         MALB1        914.69        246.88      667.81        0.69              31.44        30.48
  FBgn0032382   62253         MALB2        920.63        254.69      665.94        0.80              28.69        35.34
  FBgn0029870   31157         Marf-RNAi    953.13        302.19      650.94        1.03              30.75        32.58
  FBgn0027579   63587         mino         965.50        305.50      660.00        0.89              30.30        34.35
  FBgn0010222   62268         Nmdmc        1063.13       366.88      696.25        0.84              26.38        41.24
  FBgn0017558   28635         pdk          1064.29       374.64      689.64        1.03              23.86        46.59
  FBgn0000489   27569         pkaC3        1093.75       392.81      700.94        0.93              27.19        43.02
  FBgn0027601   55272         pudgy        1036.25       339.38      696.88        0.69              24.00        45.53
  FBgn0016715   57766         Reg2         1094.58       407.92      686.67        1.05              22.50        53.33
  FBgn0031971   43213         sirup        955.63        282.19      673.44        0.99              31.63        31.87
  FBgn0024289   34556         Sodh1        913.75        242.50      671.25        1.26              27.31        36.86
  FBgn0014031   51935         spat         922.00        281.50      640.50        0.93              31.80        29.83
  FBgn0035147   44496         UDP          1020.00       328.75      691.25        0.94              28.75        38.73
  FBgn0030904   33949         upd2 1       898.18        328.00      634.00        1.01              34.27        31.10
  FBgn0030904   33988         upd2 2       860.63        203.13      657.50        0.96              21.81        44.19

Sleep analysis {#s3}
--------------

The *Drosophila* Activity Monitor System (DAMS) detects activity by monitoring infrared beam crossings for each animal ([@bib50]). These data were used to calculate sleep information by extracting immobility bouts of 5 min using the *Drosophila* Counting Macro ([@bib51]; [@bib20]). For all experiments, flies were kept on 12:12 LD cycle. 5-7 day old female flies were briefly anesthetized with CO~2~ and placed into plastic tubes containing standard food. All flies were given 24 hr to recover after being anesthetized. Activity was recorded for 24 hr on food (ZT0-ZT24).

Protein, glucose, glycogen and triglyceride measurements {#s4}
--------------------------------------------------------

Assays for quantifying triglyceride, glycogen, free glucose and protein content of flies were performed as previously described ([@bib44]). Two bodies from female flies aged 3-5 days were homogenized in buffer containing 50 mM Tris-HCl, pH 7.4, 140mM NaCl, 0.1% Triton-X, 1X protease inhibitor cocktail (Roche). Triglyceride concentration was measured using the Infinity Triglyceride Reagent (ThermoFisher), and protein concentrations were measuring using a BCA Protein Assay Kit (Pierce Scientific). Total glucose levels were determined using the Glucose Oxidase Reagent (Pointe Scientific) in samples previously treated with 8mg/mL amyloglucosidase (Sigma) in 0.2M Sodium Citrate buffer, pH 5.0. Free glucose was measured in samples not treated with amyloglucosidase and then glycogen concentrations were determined by subtracting the free glucose from total glucose concentration. Free glucose, glycogen and triglyceride concentrations were standardized to the total protein content of each sample.

Sleep deprivation {#s5}
-----------------

Five-seven day old fruit flies were loaded into the DAM System and allowed to acclimate for 24 hr. Following acclimation, day sleep (ZT0-ZT12) was measured in undisturbed flies. Flies were then sleep deprived by mechanical stimulation every 2-3 min for 12 hr throughout the night time (ZT12-24). The mechanical stimulus was applied using a vortexer (Fisher Scientific, MultiTube Vortexer) and a repeat cycle relay switch (Macromatic, TR63122). Sleep rebound was measured the following day from ZT0-ZT12.

Arousal Threshold {#s6}
-----------------

Arousal threshold was measured using the Drosophila Arousal Tracking system (DART), as previously described ([@bib19]). In brief, individual female flies were loaded in plastic tubes (Trikinectics, Waltham, MA) and placed on plastic trays containing vibrating motors. Arousal threshold was tested with sequentially increasing vibration intensities, from 0 to 1.2 g, in 0.3 g (200 ms) increments, with an inter-stimulus delay of 15 s, once per hour over 24 hours starting at ZT0. Flies were recorded continuously using a USB-webcam (Logitech) at 1 frame per second. The vibrational stimulus and video tracking parameters, and data analysis were performed using the DART interface developed in Matlab (MathWorks, Natick, MA).

Statistical Analysis {#s7}
--------------------

The experimental data are presented as means ± SEM. Unless otherwise noted a one-way (ANOVA) followed by Tukey's post-hoc test was used for comparisons between two or more genotypes and one treatment. Unpaired *t*-test was used for comparisons between two genotypes. For arousal threshold experiment, the non-parametric Mann Whitney *U*-test was used to compare two genotypes. For two or more genotypes, a Kruskal-Wallis test followed by Dunn's *post hoc* test was used. All statistical analyses were performed using InStat software (GraphPad Software 6.0) with a 95% confidence limit (*P* \< 0.05).

Data Availability {#s8}
-----------------

Strains and plasmids are available upon request. The authors affirm that all data necessary for confirming the conclusions of the article are present within the article, figures, and tables. Supplemental material available at Figshare: <https://doi.org/10.25387/g3.7121264>.

Results {#s9}
=======

To identify genes expressed in adipose tissue that regulate sleep, we performed an RNAi screen by assaying the TRiP RNAi collection to selectively knock down genes in the fat body ([@bib7]; [@bib48]). A total of 113 genes previously reported to be upregulated in whole flies during starvation ([@bib22]) were selectively knocked down in the fat body using the GAL4 driver *CG-GAL4* ([@bib6]), and female flies were then assayed for sleep ([Figure 1A](#fig1){ref-type="fig"}) in the *Drosophila* Activity Monitors ([@bib50]). Flies with RNAi targeted to the fat body were compared to controls expressing RNAi targeted to luciferase (*CG-GAL4 \> luc-RNAi*). Knockdown of *Ade2* in the fat body (*CG-GAL4 \> Ade2-RNAi*) resulted in a loss of over 200 min of sleep, while a knockdown of the glucose transporter *[CG6484](http://flybase.org/reports/FBgn0034247.html)* (*CG-GAL4 \> CG6484-RNAi*) and *[CG6767](http://flybase.org/reports/FBgn0036030.html)*, a kinase involved in purine/pyrimidine metabolism, (*CG-GAL4 \> CG6767-RNAi*) resulted in increased sleep ([Table 1](#t1){ref-type="table"}). We chose to focus analysis on the role of *Ade*2 in sleep regulation because of the robust sleep loss phenotype identified in the screen. To verify these results, we retested the effects of *Ade2* knockdown on sleep. In agreement with the screen, sleep was reduced in *Ade2* knockdown flies (*CG-GAL4 \> Ade2-RNAi*) compared to control flies with *CG-GAL4* driving RNAi targeted to luciferase (*CG-GAL4 \> luc-RNAi*) ([Figure 1B](#fig1){ref-type="fig"}). Quantification of sleep throughout the 24 hr testing period revealed that fat body specific knockdown of *Ade2* results in sleep loss with significant reductions during both the day and night periods, suggesting *Ade2* is required for both day and nighttime sleep ([Figure 1B,C](#fig1){ref-type="fig"}).

![Ade2 functions in the fat body to promote sleep. (A) Histogram showing the distribution of sleep over 24 hr from fat body-specific knockdown of genes previously reported to be upregulated during starvation. Daily sleep is depicted as the difference between the mean of a group of ∼80 viable lines tested. Black arrow indicates the *Ade2-RNAi* control line. (B) Knock down of *Ade2* in the fat body (*CG-GAL4 \> UAS-Ade2-RNAi*; n = 84) results in a significant reduction in sleep during daytime (white; *P* \< 0.0001, t = 6.241) and nighttime (black; *P* = 0.0004, t = 3.614) compared to control flies (*CG-GAL4 \> UAS-luc-RNAi*; n = 115). Unpaired *t*-test. (C) Sleep profile of hourly sleep averages over a 24 hr experiment. White/black bars represent lights on and off, respectively. ZT denotes Zeitgeber time. Sleep is reduced in flies expressing *Ade2-RNAi* in the fat body (pink) compared to control (gray). (D) Sleep is significantly reduced in *Ade2^3-20^*/+ mutants (n = 66) and *Ade2^1-6^*/+ (n = 90) during daytime (*P* \< 0.0001 for all groups) and nighttime (*P* = 0.0002 *and p* = 0.004) compared to *w^1118^* control (n = 110). One-way ANOVA, Light, F(2, 261) = 11.20; Dark, F(2, 263)=45.91. (E) Sleep profile of hourly sleep for *Ade2^3-20^/+* mutants (dark orange), *Ade2^1-6^/+* (light orange), and *w^1118^* control (gray). All columns are mean ± SEM; \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001.](3385f1){#fig1}

The *CG-GAL4* driver is expressed in both the hemocytes and fat body.([@bib64]; [@bib6]). To identify the sleep-regulating cell-type, we knocked down *Ade2* using an additional fat-body GAL4 driver line, *r^4^-GAL4*, which exclusively labels the fat body ([@bib35]). Targeting *Ade2-RNAi* with *r^4^-GAL4* decreased both daytime and nighttime sleep compared to control flies expressing luciferase (*r^4^-GAL4 \> luc-RNAi*), phenocopying knockdown with *CG-GAL4* (Fig S1A). Conversely, knocking down *Ade2* in adult hemocytes using *hmlΔ3-GAL4* did not affect sleep (Fig S1B, ([@bib21])), supporting the notion that *Ade2* functions in the fat body to promote sleep.

To confirm that the sleep loss phenotype observed with *Ade2* knockdown was not due to off-target effects of RNAi, we assayed sleep in *Ade2* mutant *Drosophila*. Two *Ade2* mutants, *Ade2^3^*^-20^ and *Ade2^1-6^*^,^ have been generated by *P*-element excision ([@bib26]). For *Ade2^1-6^*, the deletion includes the transcription start site and part of the first coding exon resulting in a null allele ([@bib26]). While both alleles are homozygous lethal, heterozygous flies are viable. Flies heterozygous for *Ade2*^3-20^ or *Ade2*^1-6^ sleep less than *w^1118^* flies (the background control strain) during the day and night, phenocopying results obtained with RNAi knockdown in the fat body ([Figure 1D](#fig1){ref-type="fig"}). Further, a sleep profile analysis shows sleep loss is reduced throughout the day and night confirming the sleep phenotype observed in RNAi knockdown flies ([Figure 1E](#fig1){ref-type="fig"}).

Reduced sleep can be accounted for by a reduction in the total number of sleep bouts, shortened duration of individual sleep bouts, or a combination of both ([@bib20]). RNAi knockdown of *Ade2* (*CG-GAL4 \> UAS-Ade2-RNAi*) resulted in reduced sleep bout length compared to control flies (Fig S1C), while total sleep bout number was reduced during the day and increased during the night (Fig S1D). Similarly, average sleep bout length was significantly reduced in both *Ade2* mutants (*Ade2^3-20^* and *Ade2^1-6^*) compared to controls, suggesting that both *Ade2-RNAi* and mutant flies present a less consolidated sleep pattern (Fig S1E). No difference in sleep bout number was detected during the daytime in flies heterozygous for the *Ade2^3-20^* or *Ade2^1-6^* mutations compared to *w^1118^* controls, while a significant increase in sleep bout number was detected for both heterozygous mutants during the night (Fig S1F). Taken together, these experiments suggest that the short sleeping phenotype of *Ade2* deficient flies primarily derives from the shortening of sleep bouts.

To determine whether the sleep phenotype might be explained by generalized changes in locomotor activity, we analyzed waking activity (beam breaks/minute) in *Ade2* knockdown flies and flies heterozygous for each mutation. Waking activity did not significantly differ between *CG-GAL4 \> Ade2-RNAi* flies compared to control flies, though *CG-GAL4 \> Ade2-RNAi* trended toward increased waking activity during the day and the night (Fig S1G). Waking activity was significantly increased in *Ade2*^1-6^ heterozygous flies during daytime and nighttime compared to *w^1118^* controls, while *Ade2*^3-20^/+ had a significant increase in daytime but not nighttime waking activity (Fig S1H). Together, these findings suggest that disruption of *Ade2* function induces hyperactivity, in addition to shortening sleep phenocopying starved flies.

To verify that expression of *Ade2* in the fat body is sufficient for normal sleep, we selectively restored *Ade2* to the fat body in the background of *Ade2* heterozygous flies and measured sleep. Heterozygous flies with *Ade2* restored to the fat body (*CG-GAL4 \> UAS-Ade2* *Ade2*^3-20^/+) slept more than *Ade2^3-20^*/+ heterozygous mutants harboring the *UAS-Ade2* transgene without the GAL4 (*UAS-Ade2*; *Ade2^3-20^*/+) ([Figure 2A,B](#fig2){ref-type="fig"}). However, fat body expression did not fully rescue sleep, as rescue flies slept less than control flies harboring *CG-GAL4* or *UAS-Ade2* transgenes alone. Therefore, restoration of *Ade2* to the fat body partially restores sleep to *Ade2*^3-20^ mutant flies. Similarly, restoring *Ade2* to the fat body of flies heterozygous for the *Ade2*^1-6^ mutation (*CG-GAL4 \> UAS-Ade2*; *Ade2*^1-6^/+) partially restores sleep, with rescue flies sleeping significantly more than *UAS-Ade2*; *Ade2*^3-20^/+ heterozygous flies, but less than flies harboring *CG-GAL4* transgene alone ([Figure 2C,D](#fig2){ref-type="fig"}). Expression of *Ade2* in the fat body of flies heterozygous for *Ade2*^3-20^ or *Ade*2^1-6^ rescued both average sleep bout length during nighttime and sleep bout number during the day and nighttime to control levels (Fig S2A-D). Similarly, the hyperactivity phenotype seen in *Ade*2^3-20^ and *Ade2*^1-6^ heterozygous mutant flies was restored in rescue flies, and these flies did not differ from heterozygous controls (Fig S2E, S2F). To determine whether upregulation of *Ade2* in the fat body is sufficient to promote sleep, we overexpressed *Ade2* in the fat body of wildtype flies (*CG-GAL4 \> UAS-Ade2*). Sleep in these flies did not differ from transgenic controls harboring *CG-GAL4* or *UAS-Ade2* alone ([Figure 2E](#fig2){ref-type="fig"}). Taken together, these findings suggest *Ade2* expression in the fat body is necessary for normal sleep, but enhanced *Ade2* expression is not sufficient to increase sleep.

![*Ade2* expression in the fat body partially rescues sleep loss. (A) Fat body rescue of *Ade2^3-20^/+* (*CG-GAL4 \> UAS-Ade2*;*Ade2^3-20^*/+; n = 43) partially restores total sleep compared to *CG-GAL4*/+ (n = 69, *P* \< 0.0001) control and *UAS-Ade2*/+ (n = 31, *P* = 0.014). Total sleep duration in rescue flies is significantly increased compared to *Ade2^3-20^*/+;*UAS-Ade2* mutant control (n = 30, *P* \< 0.0001). One-way ANOVA, F(3, 169)=37.76. (B) Sleep profile of hourly sleep averages over a 24 hr experiment for *Ade2^3-20^* rescue (gold) compared with *Ade2^3-20^*/+;*UAS-Ade2* (yellow), *CG-GAL4*/+ (gray), and *UAS-Ade2*/+ (black) controls. White/black bars represent lights on and off. ZT denotes Zeitgeber time. (C) Total sleep is significantly increased in flies expressing *Ade2* in the fat body of *Ade2^1-6^* mutants (n = 37) compared to *Ade2^1-6^*/+;*UAS-Ade2* mutant controls (n = 39, *P* \< 0.0001). Rescue flies are significantly different than control *CG-GAL4*/+ (gray, n = 79, *P* = 0.010). *Ade2^1-6^*/+;*UAS-Ade2* mutants have reduced sleep compared to *UAS-Ade2*/+ (n = 31, *P* \< 0.0001) and *CG-GAL4*/+ (*P* \< 0.0001) controls. One-way ANOVA, F(3, 182)= 41.94. (D) Sleep profile of hourly sleep averages over a 24 hr experiment for *Ade2^1-6^* rescue (dark green) compared with *Ade2^1-6^*/+;*UAS-Ade2* (light green), *CG-GAL4*/+ (gray), and *UAS-Ade2*/+ (black) controls. (E) Total sleep did not differ between flies overexpressing *Ade2* in the fat body (*CG-GAL4 \> UAS-Ade2*; n = 64) compared to *w^1118^* (n = 55, *P* \> 0.99), *CG-GAL4*/+(n = 32, *P* = 0.74), or *UAS-Ade2*/+ (n = 31, *P* = 0.51) controls. One-way ANOVA, F(3,178)=0.43. All columns are mean ± SEM; \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001.](3385f2){#fig2}

Sleep is associated with an elevated arousal threshold where animals are less responsive to environmental stimuli ([@bib10]; [@bib25]; [@bib56]). To determine whether *Ade2* regulates arousal threshold, we measured sleep in the ***D****rosophila* **AR**ousal **T**racking system (DART, [Figure 3A](#fig3){ref-type="fig"}) ([@bib3]; [@bib19]). Briefly, the system allows for automated video-tracking combined with controlled application of a vibration stimulus. The response of sleeping animals to the vibration is used to determine the arousal threshold ([Figure 3A](#fig3){ref-type="fig"}). In agreement with infrared-based recordings, video-monitoring in the DART system confirmed reduced sleep in *CG-GAL4 \> Ade2-RNAi* flies with *Ade2* knocked down in the fat body ([Figure 3B,C](#fig3){ref-type="fig"}). No differences in arousal threshold were detected between *Ade2* knockdown and control flies during the daytime or nighttime suggesting *Ade2* affects sleep duration, but not sleep-associated changes in arousal ([Figure 3D](#fig3){ref-type="fig"}). Similarly, video monitoring in the DART system confirmed sleep duration was reduced in *Ade2*^3-20^ and *Ade2*^1-6^ heterozygous flies, but no effect on arousal threshold was detected during the day or night ([Figure 3E-G](#fig3){ref-type="fig"}). Together, these results suggest that arousal threshold is not altered in *Ade2* deficient flies.

![Arousal threshold is normal in *Ade2-RNAi* and *Ade2* mutants. (A) The *Drosophila* Arousal Tracking (DART) software records fly movement while simultaneously controlling mechanical stimuli via a digital analog converter (DAC). Mechanical stimuli are delivered to three platforms, each housing twenty flies under the control of two motors. Mechanical stimuli of increased strength were used to assess arousal threshold (shown on the computer screen). Arousal thresholds were determined hourly, starting at ZT = 0. (B) Video-tracking analysis of sleep. Sleep during daytime (white, *P* \< 0.0001, t = 6.11) and nighttime (black, *P* \< 0.0001, t = 5.47) is significantly reduced in flies expressing *Ade2-RNAi* in the fat body (*CG-GAL4 \> UAS-Ade2-RNAi*; n = 105) compared to control (*CG-GAL4 \> UAS-luc-RNAi*; n = 114). Unpaired *t*-test. (C) Sleep profile over a 24 period. White/black bars represent lights on and off. ZT denotes Zeitgeber time. *Ade2* knock down flies (turquoise) sleep less than control (black). (D) Arousal threshold during dayttime (*P* = 0.06) and nighttime (*P* = 0.07) does not differ between *CG-GAL4 \> UAS-Ade2-RNAi* (turquoise; n = 79) and control (dark green;n = 85). Mann-Whitney U; Light 2783; Dark, 2807. (E) Video-tracking analysis shows reduced sleep during daytime (*P* = 0.045) and nighttime (*P* = 0.034) in *Ade2^3-20^*/+ (n = 46) compared to *w^111^* control flies (n = 87). *Ade2^1-6^*/+ mutant flies (n = 80, *P* \< 0.0001) sleep significantly less than control flies during day and night (*P* \< 0.0001). One way-ANOVA, Light, F(2,210)=15.11; Dark, F(2,210)=17.94 (F) Sleep profile representative of data in (E). *w^1118^* control flies (black) slept more than *Ade2^3-20^*/+ (blue) and *Ade2^1-6^*/+ (gray) mutants. (G) Arousal threshold does not differ between *w^1118^* control (dark green n = 71) and *Ade2^3-20^*/+ (blue, n = 29) and *Ade2^1-6^*/+ (light blue; n= 63) during light and dark. Kruskall Wallis; Light, 6.87; Dark, 3.02. All columns are mean ± SEM; \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001.](3385f3){#fig3}

Growing evidence suggests that independent neural mechanisms regulate sleep under undisturbed conditions and the homeostatic sleep rebound following deprivation ([@bib55]; [@bib39]). To determine if sleep homeostasis is intact in *Ade2* deficient flies, we sleep deprived flies by mechanical shaking for 12-hours throughout the night, and measured sleep during the following day. The sleep deprivation protocol resulted in in significant sleep rebound in flies heterozygous for the *Ade2*^3-20^ and *Ade2*^1-6^ mutations, similar to controls ([Figure 4A,B](#fig4){ref-type="fig"}). Together, these results suggest *Ade2* is dispensable for homeostatic sleep rebound.

![Homeostatic recovery sleep is not altered in *Ade2* mutants. (A) Sleep profile for hourly sleep for 36 hr. Flies are undisturbed on the first 12 hr (ZT0-ZT12), lights on (white bars). In the subsequent night (black bars, ZT12-ZT24), flies are mechanically sleep deprived (red), and rebound is measured in the next 12 hr during the light period (ZT0-ZT12). ZT denotes Zeitgeber time. (B) *w^1118^* control (n = 78, *P* = 0.0001), *Ade2^3-20^*/+ (n = 51, *P* = 0.0002), and *Ade2^1-6^*/+ mutants (n = 50, *P* \< 0.0001) significantly rebound after sleep deprivation (purple) compared to undisturbed day (light purple). Two-way ANOVA, F(2, 352)=8.75. All columns are mean ± SEM; \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001.](3385f4){#fig4}

Flies suppress sleep and increase waking activity in response to starvation and when energy stores are depleted ([@bib35]; [@bib31]; [@bib45]). Therefore, we reasoned that the loss of sleep in *Ade2* mutants may be due to reduced energy storage. To determine if energy stores are dysregulated in *Ade2* mutants, we measured whole-body triglycerides, glycogen, and free glucose levels in fed *Ade2* loss of function flies using colorimetric assays ([@bib44]). Knockdown of *Ade2* selectively in the fat body (*CG-GAL4 \> Ade2-RNAi*) resulted in reduced triglycerides and free glucose levels ([Figure 5A-C](#fig5){ref-type="fig"}) without affecting glycogen levels. Similarly, triglyceride and free glucose levels were reduced in *Ade2*^3-20^ heterozygote flies, while glycogen levels were unaffected ([Figure 5D-F](#fig5){ref-type="fig"}). In *Ade2*^1-6^ heterozygous flies, only free glucose levels are reduced ([Figure 5E](#fig5){ref-type="fig"}). Taken together, these findings suggest *Ade2* function in the fat body is required for the normal storage of triglycerides and free glucose, supporting the notion that the reduced sleep may be caused metabolic changes that place the fly in a starvation-like state.

![Triglycerides and free glucose are altered in *Ade2* knock down and mutants. (A-C) Triglyceride (A, *P* \< 0.001, t = 0.56) and free glucose levels (B, *P* = 0.007, t = 0.25) are reduced in flies with *A*de2 knock down in the fat body (*CG-GAL4 \> UAS-Ade2-RNAi*; n = 13) compared to control flies (*CG-GAL4 \> UAS-luc-RNAi*; n = 15), while there are no significant differences in glycogen levels (C, n = 13, *P* = 0.053, t = 2.025). Unpaired *t*-test. (D-F) Triglyceride (D, n = 14, *P* \< 0.0001) and free glucose levels (E, *P* \< 0.0001) are reduced in *Ade2^3-20^*/+ mutants (n = 14) compared to *w^1118^* controls (n = 14), while there are no significant differences in glycogen levels (F, *P* = 0.75). *Ade2^1-6^* mutants (n = 15) show a reduction in free glucose levels (E, *P* \< 0.0001) compared to *w^1118^* controls. Triglyceride (D, *P* = 0.47) and glycogen (F, *P* = 0.09) stores do not differ between *Ade2^1-6^* and control flies. One-way ANOVA; TAG, F(2,40)=28.59; Free Glucose, F(2,40)=90.30; Glycogen, F(2,40)=2.45. All columns are mean ± SEM; \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001.](3385f5){#fig5}

Discussion {#s10}
==========

To our knowledge, this study represents the first genetic screen for *Drosophila* sleep regulators that specifically examine the role of non-neuronal tissue in sleep regulation. The fat body is critical for regulating energy storage in *Drosophila* and has been implicated in many behaviors including sleep regulation, courtship, circadian rhythms, and feeding ([@bib34]; [@bib63]; [@bib32]; [@bib59]). While the genetic examination of many behaviors, including sleep, have predominantly focused on investigating the neural regulation of behavior, the contribution of the fat body to behavioral regulation is less understood ([@bib27]; [@bib63]; [@bib53]). A complete understanding of behavior will require systematic investigation of the role of the fat body and other non-neuronal tissues in behavioral regulation.

The fat body-specific screen for sleep regulators described here identified that *Ade2* functions within this tissue type and is critical for normal sleep. These findings add to a growing body of literature suggesting that the adipose tissue is a critical regulator of sleep in both mammals and invertebrates ([@bib33]; [@bib59]; [@bib4]). In inbred fly lines derived from wild caught *Drosophila*, sleep duration positively associated with whole body triglyceride levels, and *Drosophila* selected for starvation resistance have elevated fat body stores and prolonged sleep ([@bib24]; [@bib43]; [@bib57]; [@bib8]). Similarly, flies mutant for the triglyceride lipase gene *brummer* have elevated triglyceride stores and an enhanced homeostatic sleep response, while mutants for the perilipin-like protein *lipid storage droplet 2* (*lsd2*) have reduced triglyceride stores and a lowered homeostatic sleep response ([@bib59]). Together, these findings suggest triglycerides, and perhaps energy stores more generally, are required for normal sleep in flies.

The role of adipose tissue in sleep regulation appears to be conserved across phyla. In mammals, leptin is secreted from adipocytes in response to nutritional state and acts on hypothalamic circuits in the brain to decrease feeding as well as increase energy expenditure ([@bib1]; [@bib13]). In addition, sleep is disrupted in leptin-deficient mice, suggesting a role for this adipose-derived hormone in regulating sleep ([@bib33]). Supporting these findings, our RNAi screen found reduced sleep in flies with fat body knockdown of *[upd2](http://flybase.org/reports/FBgn0030904.html)*, a proposed *Drosophila* ortholog of mammalian leptin ([@bib52]). The identification of *Ade2* as well as a number of additional candidate sleep regulators suggest a central role for the fat body in sleep regulation.

*Ade2* encodes a phosphoribosylformylglycinamidine synthase that plays a critical role in purine synthesis in nearly all living organisms ([@bib11]). Mutations in *Ade2*, or other components of the *de novo* purine biosynthesis pathway, have been implicated in the arrest of cell growth as well as reduced fertility and lifespan, suggesting broad biological functions of this gene ([@bib60]; [@bib40]). For example, flies heterozygous for *Ade2* mutations develop necrosis as pupae, suggesting haploinsufficiency may result in physiological abnormalities ([@bib26]). The possibility that targeted disruption of *Ade2* in the fat body disrupts development of this organ, or its function in energy storage, is supported by our findings that whole-body triglycerides and/or free glucose levels are reduced in *Ade2*-deficient flies. In addition, it is possible that reduced levels of purines themselves contribute to the sleep phenotype. In both flies and mammals, adenosine promotes sleep, and the accumulation of adenosine during periods of wakefulness is associated with increased sleep drive ([@bib29]; [@bib47]). Therefore, it is possible that a reduction in adenosine or other purinerginic signaling contributes to the sleep loss phenotype.

Our findings suggest that overexpression of *Ade2* in an otherwise wild type fly does not promote sleep, suggesting *Ade2* is essential for normal sleep, rather than variation in expression levels of this gene regulating amounts of sleep. In addition, flies with either mutation in the *Ade2* gene have a partial restoration of sleep, which suggests *Ade2* may function in the brain or other tissue to regulate sleep. *Ade2* is ubiquitously expressed and it is possible that the haploinsufficiency may be caused by dysregulated purinergic signaling or developmental abnormalities in additional brain regions. In flies, many neural circuits have been found to regulate sleep including the central complex, circadian neurons, and gustatory neurons ([@bib16]; [@bib37]; [@bib38]; [@bib23]). In addition, more recent work has revealed a critical role for non-neuronal tissue, such as glia, in sleep regulation ([@bib12]; [@bib18]). Targeted disruption of *Ade2* in additional cell types may help reveal novel insights into *Ade2* function.

In flies, starvation results in increased waking activity in addition to reduced sleep duration. We find that waking activity is significantly increased, or trends toward an increase, in *Ade2*-deficient flies, indicating that the mutant phenotype recapitulates the hyperactivity induced by starvation. Further, our analysis suggests that *Ade2* is required for normal sleep under baseline conditions, while it is dispensable for sleep homeostasis. Mechanically sleep depriving flies throughout the night results in a rebound the following day, a response that is unaffected in *Ade2*-deficient flies. These data support the notion that independent genetic mechanisms underlie regulation of sleep in undisturbed conditions and during sleep rebound. Along these lines, distinct neural circuits have been identified regulating baseline sleep and recovery sleep in *Drosophila* ([@bib55]; [@bib39]). Similarly, arousal threshold is unaffected in *Ade2* mutant flies suggesting the quality of the sleep is not dysregulated, but rather the observed phenotype is specific to sleep. Together, these findings suggest *Ade2* regulates baseline sleep duration, but may be dispensable for regulating sleep depth and homeostasis.

A growing body of evidence suggests that the levels of energy storage molecules are critical for normal sleep regulation. Starvation potently reduces whole-body triglycerides and glycogen in *Drosophila* and is associated with reduced sleep ([@bib54]). In addition, sleep duration and triglycerides are enhanced in flies selected for starvation resistance ([@bib43]). Therefore, it is possible that loss of *Ade2* in the fat body induces a chronic starvation-like state, where animals suppress their sleep. Alternatively, the fat body may regulate sleep through a mechanism that is independent of signaling energy stores.

Taken together, the confirmed role of *Ade2* and the identification of additional candidate genes that function within the fat body to either promote or inhibit sleep, supports a central role for the fat body in sleep regulation. The fat body may regulate sleep directly through controlling circulating nutrients that are sensed by the brain or by hormonal communication. In both flies and mammals, sleep-modulating neurons directly sense glucose, raising the possibility that circulating glucose levels regulate sleep ([@bib62]; [@bib41]). The identification of genes that function within the fat body, combined with genetic technology for *in vivo* imaging of sleep circuits, will allow for investigation of how non-neuronal gene regulation modulates sleep circuits within the brain. The identification of *Ade2*, and other candidate regulators of sleep, provides a platform for investigating the role of periphery-brain communication in sleep regulation.
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